Western Oncolytics' preclinical oncolytic vaccinia virus WO-12 will be developed by Pfizer in a collaboration and licensing deal that will enhance the latter's cancer vaccine technology and immuno-oncology portfolio. Under the terms of agreement, the firms will work together on preclinical and clinical development of the vaccine through the completion of early-stage trials, and Pfizer gets an exclusive option to acquire the drug.
South Carolina BIO will collaborate with the state's Department of Commerce for a nine-month study of existing life sciences companies and industry assets within the state, with the goal of expanding the industry and establishing additional biomedical jobs. Under the partnership agreement, SCBIO and the agency will each contribute $50,000 for the partnership.
BioMarin's biologics license application for Brineura, or cerliponase alfa, has been accepted for review and granted priority review status by the FDA, with a decision expected by Jan. 27. The drug is intended to treat a rare form of Batten disease called type 2 late-infantile neuronal ceroid lipofuscinosis.
According to the Economic Research Service of the Department of Agriculture, US farmers have almost universally adopted biotech seeds, and close to 40% of biotech crops planted worldwide are in the US. The report says 94% of soybean acreage, 93% of cotton acreage and 92% of corn acreage in the US contain biotech seed.
Adaptimmune Therapeutics' SPEAR T-cell therapy has been granted access to the priority medicines program by the European Medicines Agency. The drug candidate is designed to treat certain patients with metastatic or inoperable synovial sarcoma who have been previously treated with chemotherapy and have tumors expressing the NY-ESO-1 antigen.
CANbridge Life Sciences' investigational new drug application for a Phase I/II study of CAN-008 has been approved by the Taiwan FDA. The drug is used with temozolomide in patients with newly diagnosed glioblastoma multiforme during and after radiation therapy.
High levels of lead found in two turmeric spices have been discovered by the New York Department of Agriculture, prompting a recall. The items being recalled, which are both sold nationwide, are 6-ounce glass jars of Blue Mountain Jamaican Curry Powder with the UPC number 09349-19906, and Gel Spice's 3.75-ounce PET jars of Fresh Finds Ground Turmeric with the UPC number 81026-01230.
All cheese products from the Chapel Hill, N.C.-based Chapel Hill Creamery are being recalled because they were tied to a salmonella outbreak in North Carolina after a local county health officer discovered that the salmonella strain found in samples of raw milk from the firm was the same as the strain that sickened more than 50 people in the state. The products being recalled are the 14 varieties of cheese manufactured by the creamery, including all codes, sizes and packages that were sold in North Carolina, South Carolina, Georgia, Virginia and Tennessee.
The FDA has given SPR Therapeutics clearance to market its Sprint peripheral nerve stimulation system, a minimally invasive, completely reversible device designed to provide relief for chronic and acute pain. The system delivers electric pulses to the affected area via a percutaneous lead.
Edwards Lifesciences has obtained approval from Health Canada for its Edwards SAPIEN 3 heart valve, a device that comes in four sizes and is designed to treat patients with symptomatic aortic stenosis who face an increased risk for surgical replacement.
- Page 1